The 7 value drivers of TRL

Triall
Triall

--

Driving sustainable token value is imperative to every successful crypto project. The token economics of our main utility token TRL are designed to drive demand and limit supply. In this article, we’ll explain 7 key factors that will drive the value of TRL.

In a previous article we dived into the 7 growth drivers of the Triall ecosystem. In this article, we’ll put the focus on the token economics of our main utility token TRL and the underlying factors that will drive its price. We differentiate between factors that drive TRL demand and factors that limit TRL supply.

Key factors that will drive the demand for TRL include:

Release of Triall solutions: Triall will offer a growing number of applications, features, and API within its ecosystem, thereby increasing the utility of TRL. Our clients purchase Triall solutions under a tokenized Software-as-a-Service (SaaS)-subscription model. These solutions can be offered by Triall or by a connected third-party vendor (see ‘ecosystem network effects’).

Global sales channels: we are a project with global ambitions. Building on our existing network within the EU & US, we will gradually develop sales channels in other regions across the globe (APAC, Africa).

Ecosystem network effects: Triall doubles down on interoperability by offering APIs that enable previously isolated system and their users to integrate with our infrastructure (‘turning competitors into collaborators’). This will lead to synergistic network effects where we can tap into the business networks of entities that join our initiative. These network effects will in turn fuel the growth of the Triall ecosystem and the demand for TRL.

Key factors that will limit the supply of $TRL include:

Two-token system: clients interested in using Triall solutions need to pay the TRL Platform Fee for each clinical trial that wants to use Triall software under a software subscription. 65% of this fee will be locked for the entire duration of the study (with an average clinical trial lasting about 2 years). TRL is thus effectively removed from the circulating supply for each new software subscription (more info on our token economics).

Lock-up incentives: Triall offers incentives to those who lock their tokens for a set period of time. These can be clients (clinical trial professionals) who can earn membership status or token holders who can earn staking rewards.

Token burn policy: 17,5% of the TRL Platform Fee is permanently burned. This will stimulate a deflationary trend where the total TRL token supply is expected to decrease over time (more info on our burn mechanism).

Vesting schedules: all token allocation pools are bound by a vesting schedule, ranging from 5–30 months post-TGE.

--

--